Scatena Roberto: Difference between revisions
From Bioblast
m (moved Scatena Roberto to Scatena R over redirect) |
No edit summary |
||
Line 17: | Line 17: | ||
}} | }} | ||
ย | |||
== New Open Access Journal == | == New Open Access Journal == | ||
Line 28: | Line 26: | ||
|field of research=Basic | |field of research=Basic | ||
}} | }} | ||
== MITOEAGLE Feedback == | |||
:::: ''Specifically, we are studying mitochondrial metabolism in cancer cells.ย At this aim we are also participating to mt-HPP project, an Italianย consortium whose target is a definition of mitochondrial proteome inย health and disease.ย Briefly, my specific activity is to compare mitochondrial functionalย status with the mitochondrial proteome picture in different human cellย line. I do think that a "contact" between these two importantย initiatives should be useful for both.'' - '''[[Scatena R| Scatena Roberto]]''' (2016). |
Revision as of 09:22, 26 July 2016
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Scatena Roberto
MitoPedia topics: EAGLE
COST: Participant
COST WG4: WG4
Name | Scatena Roberto, Prof. PhD |
---|---|
Institution | Istituto di Biochimica e Biochimica Clinica
Policlinico A. Gemelli - Universitร Cattolica |
Address | Largo A. Gemelli 8, 00168 |
City | Rome |
State/Province | |
Country | Italy |
[email protected] | |
Weblink | |
O2k-Network Lab | IT Rome Scatena R |
New Open Access Journal
- Dr. R. Scatena is the editor of 'Cancer Stem Cells'.
Labels:
Field of research: Basic
Publications
Published | Reference | |
---|---|---|
BEC 2020.1 doi10.26124bec2020-0001.v1 | 2020 | Gnaiger E et al โ MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1 |
Bottoni 2019 Adv Exp Med Biol | 2019 | Bottoni P, Scatena R (2019) Mitochondrial metabolism in cancer. A tangled topic. Which role for proteomics? Adv Exp Med Biol 1158:1-16. |
Scatena 2019 Curr Med Chem | 2019 | Scatena R, Bottoni P (2019) The tangled mitochondrial metabolism in cancer: An innovative pharmacological approach. Curr Med Chem 27:2106-17. |
Tesori 2015 Sci Rep | 2015 | Tesori V, Piscaglia AC, Samengo D, Barba M, Bernardini C, Scatena R, Pontoglio A, Castellini L, Spelbrink JN, Maulucci G, Puglisi MA, Pani G, Gasbarrini A (2015) The multikinase inhibitor Sorafenib enhances glycolysis and synergizes with glycolysis blockade for cancer cell killing. Sci Rep 5:9149. |
Scatena 2012 Adv Exp Med Biol | 2012 | Scatena R, Bottoni P, Giardina B (eds) (2012) Advances in mitochondrial medicine. Adv Exp Med Biol 942:p461. |
Abstracts
Published | Reference | |
---|---|---|
Scatena 2018 MiP2018 | 2018 | No abstract. |
Scatena 2017 Abstract MITOEAGLE Barcelona | 2017 | Mitochondria and cancer stem cells in hepatocarcinoma. An illustrative example of a tangled methodological approach. |
Scatena 2017 MITOEAGLE Obergurgl | 2017 | Cancer stem cell differentiation induced by PPAR ligands. Which role for an inhibition of mitochondrial respiratory chain? |
MITOEAGLE Feedback
- Specifically, we are studying mitochondrial metabolism in cancer cells. At this aim we are also participating to mt-HPP project, an Italian consortium whose target is a definition of mitochondrial proteome in health and disease. Briefly, my specific activity is to compare mitochondrial functional status with the mitochondrial proteome picture in different human cell line. I do think that a "contact" between these two important initiatives should be useful for both. - Scatena Roberto (2016).